Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0002047607-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | May 26, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
34,200
Total Value
$0.00
P&L
+inf% (+$668,610.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | Common Stock | โ | May 21, 2026 | Grant/Award | 34,200 | $0.00 | $0.00 | 36,855 | Direct | โ | View Details |